SUBSTITUTED 2,2'-BIPYRIMIDINYL COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME
申请人:ARBUTUS BIOPHARMA CORPORATION
公开号:US20210251991A1
公开(公告)日:2021-08-19
The present disclosure includes substituted 2,2′-bipyrimidinyl compounds, analogues thereof, and compositions comprising the same, which can be used to treat and/or prevent hepatitis B virus (HBV) and/or hepatitis B virus (HBV)-hepatitis D virus (HDV) infection in a patient.